Researchers at Tufts University School of Medicine and the Sackler School of Graduate Biomedical Sciences at Tufts have discovered a new way to transfer DNA, thus safely protecting cells from retinal degeneration. A peptide called PEG-POD is the vehicle for therapeutic gene delivery.